https://www.pharmanow.live/latest-news/cdsco-risk-based-drug-regulation-compliance-burden-2026 2026-09-09T13:40:15+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 CDSCO Shifts To Risk-Based Drug Approvals To Ease Compliance CDSCO https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/b23c4f98-27c5-4988-982c-8214720f0a07/f5755661-aba0-4879-8750-1549000a4474.png https://www.pharmanow.live/latest-news/just-evotec-biologics-jst-018-orthopoxvirus-phase-1-dow-contract 2026-09-09T13:40:15+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Just Evotec Advances JST-018 Orthopoxvirus Cocktail To Phase 1 Just Evotec https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/b23c4f98-27c5-4988-982c-8214720f0a07/1f809cda-f11b-4a73-8147-9899584ab475.png https://www.pharmanow.live/latest-news/probiogen-transgene-expand-virus-based-therapy-manufacturing-collaboration 2026-09-09T12:05:26+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 ProBioGen & Transgene Expand Virus-Based Therapy Manufacturing ProBioGen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/20001e63-7c44-421e-a5a6-fa5a396a974a/15176e40-37ed-44eb-b37d-9dbc03675e4d.png https://www.pharmanow.live/latest-news/onyx-scientific-expands-uk-gmp-api-capacity-15-million-investment 2026-09-09T12:05:29+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Onyx Scientific Expands UK API Capacity With £1.5M Investment Onyx https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/20001e63-7c44-421e-a5a6-fa5a396a974a/bb7972a2-ea08-435c-b005-d06738bd9ebc.png https://www.pharmanow.live/latest-news/rezubio-doses-first-patients-phase-i-trial-inhaled-rz-520 2026-09-09T12:05:33+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Rezubio Begins Phase I Trial Of Inhaled Respiratory Drug RZ-520 Rezubio https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/20001e63-7c44-421e-a5a6-fa5a396a974a/14183ed3-0914-4800-9d84-235bb20c5914.png https://www.pharmanow.live/latest-news/elix-axcelead-ddp-collaborative-research-agreement-targeted-protein-degraders 2026-09-09T12:05:31+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Elix & Axcelead Partner to Accelerate Protein Degrader Discovery Elix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://s.w.org/images/core/emoji/17.0.2/72x72/2122.png https://www.pharmanow.live/latest-news/neurizon-appoints-dr-chris-bremer-ceo 2026-09-09T18:06:55+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Neurizon Appoints Dr. Chris Bremer As CEO To Lead Strategy Neurizon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/20001e63-7c44-421e-a5a6-fa5a396a974a/9f5bf424-ffff-4719-a296-3f874f2d300f.png https://www.pharmanow.live/latest-news/inhibitor-therapeutics-itraconazole-bccns-revised-fda-regulatory-strategy 2026-09-09T12:08:04+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Inhibitor Therapeutics Updates FDA Strategy for Itraconazole Inhibitor Therapeutics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a472dbf-aab6-4299-ace8-f116236f4c33/eae1e98e-3462-4a18-b557-370934a2e146.png https://www.pharmanow.live/latest-news/assembly-biosciences-exercises-us-profit-share-option-gilead-hsv-helicase-primase-inhibitor 2026-09-09T12:10:05+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Assembly Bio Exercises 40% US Profit Option With Gilead On HSV Assembly Bio https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a472dbf-aab6-4299-ace8-f116236f4c33/300bb4bb-7f4c-4237-a782-640259f46123.png https://www.pharmanow.live/latest-news/inventiva-presents-five-lanifibranor-abstracts-paris-mash-2026 2026-09-09T12:15:15+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 Inventiva Presents Five Lanifibranor Abstracts At Paris MASH 2026 Inventiva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a472dbf-aab6-4299-ace8-f116236f4c33/8d23e27e-0d1c-4f01-b926-d68c81a08696.png https://www.pharmanow.live/latest-news/fda-ddt-qualification-metrics-update-september-2026 2026-09-09T12:13:22+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 FDA Updates DDT Metrics: 160 Projects Active As Of July 2026 FDA Updates https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a472dbf-aab6-4299-ace8-f116236f4c33/e23d85ff-56de-4ba0-b7d1-0d515985af3b.png https://www.pharmanow.live/latest-news/fda-cber-blood-products-approval-pathways-bla-nda-pma-510k 2026-09-09T12:18:17+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 FDA Maps 4 Approval Pathways For Blood Products FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4dbd3692-e5b4-44a9-99ce-ab8b6ef59e9f/0a872d01-50f4-4e09-b8f9-6ffae647b85e.png https://www.pharmanow.live/latest-news/fda-clarifies-cber-jurisdiction-nda-anda-blood-products 2026-09-09T12:21:05+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 FDA Clarifies CBER Control Over Blood NDA And ANDA Paths FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4dbd3692-e5b4-44a9-99ce-ab8b6ef59e9f/45793206-9fe9-47a0-9e99-064c0bb1560d.png https://www.pharmanow.live/latest-news/fda-updates-general-biologics-guidance-library-cmc-gmp-documents 2026-09-09T12:23:39+05:30 Pharma Now en 2026-09-09T00:00:00+05:30 FDA Updates Biologics Library With CMC And GMP Reference Docs FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4dbd3692-e5b4-44a9-99ce-ab8b6ef59e9f/64420afd-aa9d-4e9f-bd65-b5747e89bf14.png https://www.pharmanow.live/latest-news/alkem-launches-renocia-exo-india-first-patented-ginsenoside-exosome-hair-growth-serum 2026-09-09T11:42:54+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Alkem Launches Renocia Exo, India's First Patented Ginsenoside Exosome Hair Growth Serum Alkem https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/alkem-launches-renocia-exo-hair-growth-serum20260909114238.webp https://www.pharmanow.live/latest-news/ocugen-doses-first-patient-phase-3-armada3-trial-ocu410-geographic-atrophy 2026-09-09T11:50:07+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Ocugen Doses First Patient in Phase 3 ArMaDa3 Trial of OCU410 for Geographic Atrophy Ocugen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ocugen-doses-first-patient-armada3-geographic-atrophy20260909114617.webp https://www.pharmanow.live/latest-news/biocon-secures-10-year-pertuzumab-supply-deal-brazil-pdp-framework 2026-09-09T11:54:04+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Biocon Secures 10-Year Pertuzumab Supply Deal with Brazil Under PDP Framework Biocon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/biocon-secures-pertuzumab-supply-deal-brazil20260909115359.webp https://www.pharmanow.live/latest-news/veru-advances-sabizabulin-phase-2-daraxonrasib-resistant-pancreatic-cancer 2026-09-09T11:59:45+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Veru Advances Sabizabulin into Phase 2 After Preclinical Data Shows Activity in Daraxonrasib-Resistant Pancreatic Cancer Veru https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/veru-sabizabulin-phase-2-pancreatic-cancer20260909115928.webp https://www.pharmanow.live/latest-news/gri-bio-phase-2a-gri-0621-nine-pillar-mechanism-ipf-ers-2026 2026-09-09T12:08:07+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 GRI Bio Presents Phase 2a Data Mapping GRI-0621's Nine-Pillar Mechanism of Action in IPF https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/gri-bio-phase-2a-gri-0621-ipf-mechanism20260909120315.webp https://www.pharmanow.live/latest-news/pmv-pharmaceuticals-appoints-philip-herman-cco-rezatapopt-nda-2027 2026-09-09T12:16:18+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 PMV Pharmaceuticals Appoints Philip Herman as CCO Ahead of 2027 Rezatapopt NDA Submission PMV https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/pmv-pharmaceuticals-appoints-herman-cco-rezatapopt20260909121611.webp https://www.pharmanow.live/latest-news/infex-therapeutics-phase-iia-resp-x-pseudomonas-bronchiectasis-ers-2026 2026-09-09T12:18:48+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Infex Therapeutics Reports Phase IIa Signal in Bronchiectasis Infex Therapeutics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/infex-therapeutics-phase-iia-resp-x-bronchiectasis20260909121836.webp https://www.pharmanow.live/latest-news/novartis-harbor-phase-iii-misses-primary-endpoint-dm1-del-desiran 2026-09-09T12:22:02+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Novartis HARBOR Phase III Trial Misses Primary Endpoint Novartis https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novartis-harbor-phase-iii-misses-endpoint-dm120260909121949.webp https://www.pharmanow.live/latest-news/cormica-opens-medical-device-chemistry-lab-bradford-centre-of-excellence 2026-09-08T13:43:47+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Cormica Opens Medical Device Chemistry Lab in Bradford Cormica https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.cormica.com/wp-content/uploads/2026/09/cormica-bradford-medical-device-chemistry-laboratory-opening-600x600.jpg https://www.pharmanow.live/latest-news/hrv-pharma-rs-150-crore-synthetic-peptides-hpapi-oncology-expansion 2026-09-09T12:22:39+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 HRV Pharma Commits Rs. 150 Crore to Build API Capacity HRV Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/hrv-pharma-synthetic-peptides-hpapi-oncology20260909122225.webp https://www.pharmanow.live/latest-news/sanofi-tricog-ai-cardiac-diagnostics-partnership 2026-09-08T15:37:54+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Sanofi Signs Three-Year Partnership with Tricog to Scale AI Cardiac Diagnostics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sanofi-tricog-ai-cardiac-diagnostics-partnership20260908143207.webp https://www.pharmanow.live/latest-news/pfizer-discontinues-minipress-xl-global-manufacturing-cessation 2026-09-08T15:43:44+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Pfizer Discontinues Minipress XL Following Global Manufacturing Cessation Decision https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/pfizer-discontinues-minipress-xl-manufacturing20260908154327.webp https://www.pharmanow.live/latest-news/novo-nordisk-step-young-phase-3-pediatric-semaglutide-obesity 2026-09-08T15:46:24+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Novo Nordisk Achieves Primary Endpoint in STEP Young Phase 3 Trial for Pediatric Semaglutide Indication https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novo-nordisk-step-young-pediatric-semaglutide-obesity20260908154615.webp https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-breast-cancer-serena-6 2026-09-08T15:50:35+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 AstraZeneca Wins FDA Nod After SERENA-6 Cuts Progression Risk 56% AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/astrazeneca-fda-accelerated-approval-serena-6-breast-cancer20260908155021.webp https://www.pharmanow.live/latest-news/fosun-pharma-hk1-billion-h-share-buyback-gland-pharma-stake-disposal 2026-09-08T15:54:55+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Fosun Pharma Secures HK$1B H-Share Buyback via Gland Stake Sale Fosun Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fosun-pharma-hk1-billion-buyback-gland-pharma-stake20260908155440.webp https://www.pharmanow.live/latest-news/indian-immunologicals-abhayrab-quality-dispute-cdsco-batch-records 2026-09-07T11:07:07+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Indian Immunologicals Disputes Abhayrab Findings, Submits Records Indian Immunologicals https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e0d7c157-6648-4d52-b1b0-68ccb7465d87/6f0e8972-e93a-480e-8821-a8be9374f779.png https://www.pharmanow.live/latest-news/rezubio-fda-nmpa-ind-clearances-rz-520-chronic-respiratory-disease 2026-09-08T15:58:55+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Rezubio Gains FDA, NMPA IND Clearances for Inhaled RZ-520 Rezubio https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/rezubio-fda-nmpa-ind-clearances-rz-52020260908155844.webp